Blog - QualityStocks

MondayMar 20, 2023 3:15 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Enters Licensing Agreement with Qiantu Motors to Manufacture, Distribute EV Supercar

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is partnering with Qiantu Motors to launch the DragonFLY K50 in the Americas. As part of an exclusive licensing agreement, Qiantu Motors and affiliated companies granted MULN the North and South American IP and distribution rights allowing assembly and distribution. The announcement noted that Mullen will finalize vehicle engineering in compliance with U.S. regulations with final assembly planned for its Indiana-based manufacturing facility. The EV supercar will be sold under the Mullen GT & GTRS brands with performance specs anticipated to include going from 0 to 60 miles per hour…

MondayMar 20, 2023 2:48 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Represent the Future of Farming

Advanced Container Technologies’ (OTC: ACTX) innovative controlled environment farms – GrowPods – enable almost anyone to start growing leafy greens and certain vegetables 365 days a year in any environment. GrowPods are insulated, heated and cooled and can provide year-round, fresh produce for businesses, community groups, entrepreneurs, restaurants, grocery stores, and farmers. Even traditional farmers use GrowPods to supplement their income to cultivate high-profit herbs and produce year-round. ABC News in Denver reported that shipping container farming provides the opportunity to “grow anything, anywhere at any time,” including the upside of controlled environment farms located in urban areas to provide…

MondayMar 20, 2023 1:02 pm

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Rebrands, Including Changing Name to IGC Pharma, as Part of ‘Major Milestone’ Alignment

India Globalization Capital (NYSE American: IGC) (dba IGC Inc.) will begin operating under the name IGC Pharma Inc. (dba IGC), effective March 30, 2023; the name change is one aspect of the company’s rebranding strategy designed to better reflect its strategic focus and vision for the future. IGC’s common stock will trade on NYSE American exchange under the new name on March 31, 2023; the symbol will remain the same: IGC. According to the announcement, the change in name to IGC Pharma better represents the company’s focus as a developer of drug assets for treating diseases, including but not limited to…

MondayMar 20, 2023 12:45 pm

Paris Blockchain Week to Leverage the Growing Significance of Blockchain Technology

Experienced professionals, policy leaders, blockchain enthusiasts, professionals, and investors in the blockchain industry, are attending the 4th edition of Paris Blockchain Week (“PBW”) being held from March 20-24, 2023 at the Carrousel du LOUVRE in the heart of Paris’ famous palace and largest museum in the world. Paris Blockchain Week is the top international conference devoted to professionals in the Web3 and blockchain space. This 4th edition of the Paris Blockchain Week is Europe’s leading blockchain event, covering: Web3, NFTs, decentralized finance, and metaverse, with 10,000+ attendees from across the world. It’s a great opportunity for blockchain fans to learn,…

MondayMar 20, 2023 12:00 pm

EV Charging Summit & Expo To Discuss Important Issues Of EV Charging

The EVCS & Expo event is being held on March 29-31, 2023 at the Mirage Hotel, Las Vegas. Company executives, directors, professionals, government organizations, and stakeholders of EV and allied industries, are invited to attend the event. The event focuses on important issues of financing, infrastructure, operability, and ROI for EV charging. Exhibitors participating in the event will pitch their business ideas and showcase real solutions, novel ways of cost savings, and technological advances to infrastructure. All commercial and government organizations can leverage the platform to gain in-depth knowledge and insights into hassles, challenges and solutions for EV charging infrastructures.…

MondayMar 20, 2023 11:15 am

GeoSolar Technologies Inc. Seeks to Curtail Household Emissions as IEA Announces Greenhouse Gas Output Hits Record High in 2022

A recent report published by the IEA revealed that global carbon emissions rose by 0.9% YoY in 2022, hitting a record 36.8 gigatons With households accounting for 30% of global greenhouse gas emissions, GeoSolar Technologies has focused on building out renewable energy solutions for homes U.S. households have been slow to adopt renewable energy. As of 2020, only 3.7% of U.S. households derived their electricity from solar energy versus nearly 33% in Australia The recently passed Inflation Reduction Act (“IRA”) in the U.S. will seek to augment that figure in the U.S., with homeowners able to benefit from an array…

MondayMar 20, 2023 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Combines Power of Quantum Computing with Cloud, Machine Learning, to Fuel Business Efficiencies, Innovation

Boston Consulting Group estimates the near-term total addressable market (“TAM”) for quantum hardware, software and service providers, to be $400 million to $1 billion within the next three to five years Annealing technology represents near-term quantum tech that is solving enterprise optimization problems today for key industries D-Wave’s quantum computing systems and services are exploring and addressing computationally complex problems, including supply chain optimization, fraud detection, and employee scheduling New trends in technology are creating high demand for solutions that can solve increasingly computationally complex problems. That, coupled with accelerated adoption of artificial intelligence and machine learning, are some of…

MondayMar 20, 2023 9:45 am

HeartBeam Inc. (NASDAQ: BEAT) Focuses on CV Solutions as Study Shows CV Disease Rising Among Young Adults

New data show rising burden of most cardiovascular risk factors among young adults aged 20 to 44 in the U.S. Findings are “extremely concerning” as expert notes “we’re witnessing a smoldering public health crisis” HeartBeam has developed the first and only 3D-vector electrocardiogram for heart attack detection anytime, anywhere A recent study shows that risk factors for cardiovascular (“CV”) disease are rising among young adults (https://ibn.fm/jvjFN). Studies like this that provide critical information regarding CV disease highlight the ongoing urgency of HeartBeam’s efforts. HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector electrocardiogram…

MondayMar 20, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Ramping Up Proprietary REE Processing Solution, Plans for Mine Prospect as China Tech War Grows Hotter

Rare earth element (“REE”) processing solutions developer Ucore Rare Metals Inc. is preparing to demonstrate the prowess of its proprietary RapidSX (TM) technological advantage as an improvement over standard REE ore separation processes REE production has become a matter of strategic importance to American industries and tech-based military applications, as China has built global control of vital REE markets and demonstrated a willingness to stop REE exports during international disputes Ucore is preparing to launch construction of a Strategic Metals Complex (“SMC”) in Louisiana later this year after demonstrating RapidSX (TM) potential at its Canadian base Ucore’s SMC will be…

FridayMar 17, 2023 1:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moving Closer to Providing Alternative Hypertension Treatment with DehydraTECH(TM)-CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently reported additional findings from its most comprehensive clinical study yet, HYPER-H21-4. “The findings showed that DehydraTECH-CBD resulted in a statistically significant reduction in average baseline serum catestatin concentrations of 13.50 ng/mL to just 9.65 ng/mL after five weeks of dosing, representing a 28.5% drop. In addition, mean arterial pressure significantly dropped by 4.26 ± 1.26 mm/Hg following the five weeks of DehydraTECH-CBD dosing. No statistically significant reductions in catestatin concentrations were identified in the placebo group,” a recent article reads. “Given the growing demand for alternative anti-hypertensive…

Site Search

Company Search